← Back to directory

Ida Vanessa Döederlein Schwartz

Researcher Next ID · RN-037885

Researcher · Biochemistry, Genetics and Molecular Biology

Universidade Federal do Rio Grande do Sul

Porto Alegre, Brazil

Accepting doctoral researchersFunding unknown
Works count
619
Citation count
7,959
H-index
47
i10-index
180

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lysosomal Storage Disorders Research
Metabolism and Genetic Disorders
Glycogen Storage Diseases and Myoclonus
Folate and B Vitamins Research
Trypanosoma species research and implications

Publications

  • Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

    Annals of the Rheumatic Diseases · 2022 · 10.1136/annrheumdis-2022-222629

  • Gender, Race and Parenthood Impact Academic Productivity During the COVID-19 Pandemic: From Survey to Action

    Frontiers in Psychology · 2021 · https://doi.org/10.3389/fpsyg.2021.663252

  • Impact of COVID-19 on academic mothers

    Science · 2020 · https://doi.org/10.1126/science.abc2740

  • Parent in Science: The Impact of Parenthood on the Scientific Career in Brazil

    · 2019 · 10.1109/ge.2019.00017

  • Phenotype, treatment practice and outcome in the cobalamin‐dependent remethylation disorders and MTHFR deficiency: Data from the E‐HOD registry

    Journal of Inherited Metabolic Disease · 2019 · 10.1002/jimd.12041

  • The germline mutational landscape of BRCA1 and BRCA2 in Brazil

    Scientific Reports · 2018 · 10.1038/s41598-018-27315-2

  • Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians

    Molecular Genetics and Metabolism · 2017 · 10.1016/j.ymgme.2017.08.002

  • Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)

    American Journal of Hematology · 2017 · 10.1002/ajh.24957

  • Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review

    Orphanet Journal of Rare Diseases · 2010 · 10.1186/1750-1172-5-14

  • Evidence that l-Carnitine and Selenium Supplementation Reduces Oxidative Stress in Phenylketonuric Patients

    Cellular and Molecular Neurobiology · 2010 · 10.1007/s10571-010-9636-3

  • Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long‐term pulmonary function in patients treated with recombinant human N‐acetylgalactosamine 4‐sulfatase

    Journal of Inherited Metabolic Disease · 2010 · 10.1007/s10545-009-9007-8

  • Multidisciplinary Management of Hunter Syndrome

    PEDIATRICS · 2009 · https://doi.org/10.1542/peds.2008-0999

  • l-Carnitine Blood Levels and Oxidative Stress in Treated Phenylketonuric Patients

    Cellular and Molecular Neurobiology · 2008 · 10.1007/s10571-008-9313-y

  • Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

    Molecular Genetics and Metabolism · 2008 · https://doi.org/10.1016/j.ymgme.2008.04.001

  • Mucopolysaccharidoses in Brazil: What happens from birth to biochemical diagnosis?

    American Journal of Medical Genetics Part A · 2008 · 10.1002/ajmg.a.32320

  • A clinical study of 77 patients with mucopolysaccharidosis type II

    Acta Paediatrica · 2007 · 10.1111/j.1651-2227.2007.00212.x

  • Brain MRI in mucopolysaccharidosis

    Neurology · 2007 · 10.1212/01.wnl.0000269782.80107.fe

  • Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study

    The Journal of Pediatrics · 2006 · https://doi.org/10.1016/j.jpeds.2005.12.014

  • Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)

    American Journal of Medical Genetics Part A · 2005 · 10.1002/ajmg.a.30579

  • Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses

    Journal of Inherited Metabolic Disease · 2004 · 10.1007/s10545-005-0069-y

  • CNS involvement in Fabry disease: Clinical and imaging studies before and after 12 months of enzyme replacement therapy

    Journal of Inherited Metabolic Disease · 2004 · 10.1023/b:boli.0000028794.04349.91

  • Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses

    Journal of Inherited Metabolic Disease · 2004 · 10.1007/s10545-005-5673-3

  • Clinical and biochemical study of 28 patients with mucopolysaccharidosis type VI

    Clinical Genetics · 2004 · 10.1111/j.1399-0004.2004.00277.x

  • Development and Testing of New Screening Method for Keratan Sulfate in Mucopolysaccharidosis IVA

    Pediatric Research · 2004 · 10.1203/01.pdr.0000113767.60140.e9

  • Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients

    Molecular Genetics and Metabolism · 2003 · 10.1016/s1096-7192(02)00200-7

Current projects

    No projects listed.